• Catalan
  • Dutch
  • English
  • German
  • Spanish
Health Outcomes Observatory
  • Home
  • Project
    • About H2O
    • Vision & Objectives
    • Impact
    • Work Packages
    • Governance
  • Participants
    • Partners
    • Associated Collaborators
    • Advisory Boards
  • Observatories
    • What are the Observatories?
    • How do they work?
  • Patients
    • H2O, with and for patients
    • FAQs
    • PROs Leaflet
  • News
    • News
    • Press Releases & Announcements
    • Events
    • Blogs
  • Resources
    • Publications
    • Deliverables
    • Factsheets
  • Contact
  • Search
  • Menu Menu
  • Home
  • Project
    • About H2O
    • Vision & Objectives
    • Impact
    • Work Packages
    • Governance
  • Participants
    • Partners
    • Associated Collaborators
    • Advisory Boards
  • Observatories
    • What are the Observatories?
    • How do they work?
  • Patients
    • H2O, with and for patients
    • FAQs
    • PROs Leaflet
  • News
    • News
    • Press Releases & Announcements
    • Events
    • Blogs
  • Resources
    • Publications
    • Deliverables
    • Factsheets
  • Contact
Marc Ferrante speaks at a conference

An interview with WP4 co-lead Marc Ferrante

14th May 2021/in news /by Renn

Charlotte Hedin, a specialist in gastroenterology and internal medicine at Karolinska University Hospital and an active member of Work Package 4 (IBD), recently profiled Marc Ferrante for the European Crohn’s and Colitis Organization’s Y-ECCO Interview Corner. Marc Ferrante is a professor at KU Leuven and specialist in gastroenterology and hepatology at UZ Leuven and co-lead of Work Package 4.

The interview covers the backstory of how Marc became involved with IBD research and activism, his inspirations and philosophy, current projects, and future goals. As part of the interview Marc highlights the H2O project and its potentially transformative benefits for the IBD community, including patients and clinicians.

Although Marc’s initial plan when starting out in medicine focused on Africa and Médecins Sans Frontières, life intervened and he became passionate about IBD after pursuing a PhD in the field on the advice of his mentors. His experiences with work and travel in Africa, post-doctoral research into the potential of organoids in IBD at a basic science lab, and his love of clinical work with patients all influence his approach now as a physician, researcher, professor, and activist in the field. Marc’s focus now is on improving quality of care using health data, including patient-reported outcomes. He is working on this at the national level in Belgium and at the European level. As he points out,

“What we want to achieve is to put the patient more in the middle of what we are doing. Not to only look at the classical outcomes we have for clinical trials but to focus on patient-reported outcomes (PROs). We are already implementing some PROs in clinical trials such as the PRO-2 in Crohn’s Disease and Ulcerative Colitis, but there are likely many more outcome factors that we could ask our patients about and that may in the future become more important in deciding whether a product is valuable as a treatment. We strive for endoscopic remission and nowadays even for histological remission, but maybe we should strive for a patient who has an improvement in their PROs as well.”

The effort to standardise and expand PRO collection is a core component of the H2O project. Furthermore, he stresses the importance of integrating health data like this into existing electronic medical records systems to inform clinical care and drive improvements in quality. The H2O observatory model will take this a step further by making health data, standardised across multiple European countries, available to stakeholders for research purposes so that aggregated outcomes can benefit not only larger patient populations, but health systems and health care overall.

Of course, Marc also sees the benefit of outcomes collection and data visualisation as a clinician.

“I would like to have a system where, before the patient enters the office, I already know in which direction the patient wants the consultation to go…If the patient has highlighted problems with for example fatigue, I can then ask directly about fatigue. Often the patient will bring up the problem at the end of the consultation, so it is a great advantage if you as the physician or nurse can bring it up directly and say ok, let’s talk about fatigue because I see based on your answer that it is quite important for you. I think in this way projects like H2O can help to individualise the patient contact and facilitate patient empowerment.”

The patient side of this equation must be at least equally considered and is key to the sustainability of the H2O project and model. Without wide acceptance by patients, which can only happen if the project’s offerings are actually valuable for them, there can never be outcomes collection at a large scale. Marc addresses the central role of patients in the project,

“They are in the front line; their ideas will be regarded as the most important ones. We will use the classic Delphi process to come up with the list of factors that we want to use, and patients are in the core panel and also in the focus groups and their opinions will be prioritised in generating the list of outcomes. Patients also need to be involved in defining what the value is for the patient in filling out these questionnaires: patients will do it once or twice in the clinic, but if they don’t clearly see an added value, they will stop doing it and that, of course, is not what we want – we want them to be consistently and repeatedly filling out these questionnaires. For us as physicians and scientists the benefit is that we can do science, set up trials or find out about these diseases, but the benefit to the patient has to be clear, too.”

The strength of H2O lies in its multidisciplinary, public-private consortium, and especially in the individual people who are working on the project. Follow H2O for more updates on the work done by Marc, Charlotte, and all of WP4!

Read the full interview at the ECCO website.

European Crohn's and Colitis Organisation logo

Share this entry
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
https://health-outcomes-observatory.eu/wp-content/uploads/2021/05/0921203M_Ferrante.jpg 533 800 Renn https://health-outcomes-observatory.eu/wp-content/uploads/2021/01/H2O-logo-hor-300x98.png Renn2021-05-14 17:10:102021-05-14 17:10:10An interview with WP4 co-lead Marc Ferrante

NEWSLETTER

Sign up to stay informed

Recent Posts

  • Joint statement from H2O and ICHOM announcing a new collaboration agreement
  • Creation of the independent legal entity of the H20 (Health Outcomes Observatory) project in Spain.
  • H2O response to the new European Health Data Space (EHDS)
  • Unleashing the Power of PROS – an H2O Hosted Conversation

ACKNOWLEDGEMENT

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 945345-2. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Trial Nation and JDRF.

About IMI

The Innovative Medicines Initiative is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). It is working to improve health by speeding up the development of the next generation of medicines, particularly in areas where there is an unmet medical or social need. It works by facilitating collaboration between the key players involved in health research, including universities, research centres, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is the world’s biggest public-private partnership (PPP) in the life sciences. http://www.imi.europa.eu/

Legal notice
Privacy Policy
Cookies Policy

       




H2O seeks bids for running its new international observatory Why I joined H2O, a video by IBD patient Evelyn Groß
Scroll to top
Non exempt cookies, proprietary cookies and third-party cookies are used to identify the browsing preferences and habits of users and to offer a better experience. Please consult our cookie policy here.
Cookie SettingsAccept all Reject All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT